—Տ°ˆγHŠwEξ•ρŠwƒXƒLƒ‹ƒAƒbƒvuΐ

‚l‚d‚hƒZƒ“ƒ^[ƒgƒbƒv | ƒTƒCƒgƒ}ƒbƒv | ‚¨–⍇‚ν‚Ή

—Տ°ˆγHŠw—Z‡Œ€‹†„i•”–ε—Տ°ˆγHŠwƒI[ƒvƒ“‘εŠw‰@‹³ˆη„i•”–ε—Տ°ˆγHŠwEξ•ρŠwƒXƒLƒ‹ƒAƒbƒvuΐ
Global COE Program’nˆζ˜AŒg‹¦‹c‰ο
‘γ•\ˆ₯ŽA „i‘̐§ uŽtˆκ—— κ”C‹³ˆυ‚ΜΠ‰ξ ‹³ˆηƒvƒƒOƒ‰ƒ€ u‹`ƒXƒPƒWƒ…[ƒ‹ ‰οκˆΔ“ΰ E-leaerning ‰ž•ε—v€E‰ž•ε—pŽ† Q&A
MEIƒZƒ“ƒ^[@PRMOVIE

H22”N“xu‹`ˆκ——ƒ_ƒEƒ“ƒ[ƒh





H22”N“x ‹³ˆηƒvƒƒOƒ‰ƒ€



—Տ°ˆγŠw‘˜_(zŠΒŠν)

—Տ°ˆγŠw‘˜_(Α‰»Šν)

ˆγH—Z‡—Μˆζ‚Μ—Ο—‚Ζ’mΰ



f’fŽ‘—ΓƒVƒXƒeƒ€Šw

ˆγ—p‰ζ‘œξ•ρŠw

[ƒAƒhƒoƒ“ƒXƒNƒ‰ƒX]

PET•ͺŽqƒCƒ[ƒWƒ“ƒO



ƒoƒCƒIƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“

ƒoƒCƒIƒCƒ“ƒtƒHƒ}ƒeƒBƒNƒX



ζ’[ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹



ƒƒfƒBƒJƒ‹ƒCƒ“ƒtƒHƒ}ƒeƒBƒNƒX

[ƒAƒhƒoƒ“ƒXƒNƒ‰ƒX]

ˆγ–ς•i‚ΜŠJ”­Œv‰ζ

—Տ°–ς—Šw‚ΜŠξ‘b

—Տ°ŽŽŒ±ƒfƒUƒCƒ“‚ΜŠξ‘b

—Տ°ŽŽŒ±ƒfƒUƒCƒ“‚ΜŽΐΫ

ˆγŠw“ŒvŠwƒTƒ}[ƒXƒN[ƒ‹A

ˆγŠw“ŒvŠwƒTƒ}[ƒXƒN[ƒ‹B

ˆγ–ς•i‚̐RΈ‚Ζ‹K§

ˆγ—Γ‹@Šν‚π„‚ι—Տ°•]‰Ώ

—Տ°ŽŽŒ±‚Μƒf[ƒ^ƒ}ƒlƒWƒƒ“ƒg

ŠΟŽ@Œ€‹†‚Μ“Œv“I•ϋ–@

ˆγ–ς•i‚ΜŒ€‹†ŠJ”­FPharmacogenomicsŽŽŒ±












‘εγ‘εŠw—Տ°ˆγHŠw—Z‡Œ€‹†‹³ˆηƒZƒ“ƒ^[

The Center for Advanced Medical Engineering
and Informatics, Osaka University